课题基金 / 基金详情

NF-KB ACTIVATION BY BRONCHIOLAR EPITHELIUM IN ASTHMA

NF-KB ACTIVATION BY BRONCHIOLAR EPITHELIUM IN ASTHMA
哮喘中细支气管上皮的 NF-KB 激活
批准号:
6140051
负责人:
Matthew E Poynter
金额:
$3.04万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
未结题
起止时间:
2000-09-30 至

项目摘要

项目成果

Matthew E Poynter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The hypothesis to be investigated in this proposal is that activation of the transcription factor, Nuclear Factor-kappaB (NF-kappaB), in epithelial cells of conducting airways plays an initiative role in the development of the pathologic phenotype observed in a murine model of allergic asthma. The hypothesis will be tested in 3 specific aims. Specific Aim number 1 will be to determine the time-course of NF-kappaB activation in bronchiolar epithelium following allergen challenge and correlation with induction of inflammation and alterations in pulmonary function. Specific Aim number 2 will be to examine the mRNA and protein expression of the NF-kappaB regulated genes RANTES, eotaxin, and IL-6 in bronchiolar epithelial cells following immunization and challenge with allergen. Finally, Specific Aim number 3 will be to determine whether inhibition of NF-kappaB activation, using a transgenic mouse expressing a IkappaBalpha superrepressor exclusively in bronchiolar epithelium, prevents the generation of inflammatory responses and alterations in pulmonary physiology associated with asthma. Results of these studies will demonstrate the importance of NF- kappaB signaling cascades in bronchiolar epithelium, in development of allergic asthma. This knowledge will provide the mechanistic foundation for the design of more effective therapies for allergic asthma and other inflammatory lung diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ketone Body Supplementation in Obese Asthma
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
海外基金